Home > Products > HER2 & VEGF
> Recombinant Anti-HER2 x Anti-VEGF VHH BispecificAntibody (IgG-VHH)
Recombinant Anti-HER2 x Anti-VEGF VHH BispecificAntibody (IgG-VHH) (CAT#: IGVHH-050)
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (IgG-VHH) is designed to be expressed as a LC and an extended HC with VHH moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can bind two factors simultaneously and inhibit cell proliferation. It is designed for the research of Colorectal cancer; Breast cancer; Lung cancer; Renal cell cancer (RCC); Glioma cancer; Glioblastoma; Ovarian cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-HER2 x Anti-VEGF VHH BispecificAntibody (IgG-VHH) (IGVHH-050). Click the button below to contact us or submit your feedback about this product.